[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100349104":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":23,"responsibleParty":93,"collaborators":7,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":97,"sex":102,"minAge":103,"maxAge":7,"enrollmentInfo":104,"targetDuration":7,"studyType":107,"phases":7,"briefSummary":108,"conditions":109,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Blood sampling","Blood sampling at each clinical follow-up visit.",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Fabien ZOULIM, Pr","CONTACT","04 26 10 93 55","+33","fabien.zoulim@chu-lyon.fr",{"name":20,"role":15,"phone":21,"phoneExt":17,"email":22},"Massimo LEVERO, Pr","04 72 68 19 79","massimo.levrero@inserm.fr",[24,39,52,63,75,84],{"facility":25,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Hepatology department - Groupement Hospitalier Nord - Hôpital de la Croix-Rousse","RECRUITING","Lyon","69004","France","FR",{"type":32,"coordinates":33},"Point",[34,35],4.84789,45.74906,{"lat":35,"lon":34},[38],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},{"facility":40,"status":26,"city":27,"state":7,"zip":41,"country":29,"countryCode":30,"cosmosGeoPoint":42,"geoPoint":44,"contacts":45},"Hôpital de la Croix-Rousse - Service de maladies infectieuses et tropicales","69317",{"type":32,"coordinates":43},[34,35],{"lat":35,"lon":34},[46,50],{"name":47,"role":15,"phone":48,"phoneExt":17,"email":49},"Matthieu GODINOT, MD, PhD","04 72 07 19 79","matthieu.godinot@chu-lyon.fr",{"name":47,"role":51,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":53,"status":26,"city":27,"state":7,"zip":54,"country":29,"countryCode":30,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"Department of Hepato-gastroenterology and pediatric nutrition - Hôpital Femme-Mère Enfant","69677",{"type":32,"coordinates":56},[34,35],{"lat":35,"lon":34},[59],{"name":60,"role":15,"phone":61,"phoneExt":17,"email":62},"Noémie Laverdure, MD, PhD","4 72 12 94 34","noemie.laverdure@chu-lyon.fr",{"facility":64,"status":65,"city":66,"state":7,"zip":67,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":7},"Gastroenterology and Hepatology department - • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","TERMINATED","Milan","20122","Italy","IT",{"type":32,"coordinates":71},[72,73],9.18951,45.46427,{"lat":73,"lon":72},{"facility":76,"status":65,"city":77,"state":7,"zip":78,"country":68,"countryCode":69,"cosmosGeoPoint":79,"geoPoint":83,"contacts":7},"Gastroenterology and Hepatology department - • Università degli Studi di Palermo","Palermo","90133",{"type":32,"coordinates":80},[81,82],13.3636,38.1166,{"lat":82,"lon":81},{"facility":85,"status":65,"city":86,"state":7,"zip":87,"country":68,"countryCode":69,"cosmosGeoPoint":88,"geoPoint":92,"contacts":7},"Infectious diseases and hepatology unit - Azienda Ospedaliero","Parma","43126",{"type":32,"coordinates":89},[90,91],10.32618,44.79935,{"lat":91,"lon":90},{"type":94,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100349104","creation-of-a-cohort-for-the-quantitation-and-characterization-of-circulating-viral-rnas-as-a-new-biomarker-of-hepatitis-b-functional-cure-100349104",false,"NCT03825458","Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.","CirB-RNA","Inclusion Criteria:\n\n* Adults patients and minor children over 6 years of age (in Lyon) with acute or chronic hepatitis B or presenting with HBsAg loss (with\u002Fwithout HBs seroconversion). (Co-infected patients with HDV and\u002For HCV and\u002For HIV are eligible)\n* Patients requiring blood sampling for medical care at the time of the medical appointment.\n* Informed patients who do not refuse to participate.\n* Persons not affiliated to a social security scheme and persons receiving medical assistance from the state may be asked to participate in the study\n\nExclusion Criteria:\n\n* Patients participating at the time of the inclusion to an interventional trial evaluating a drug likely to interfere with this study.\n* Persons deprived of their liberty by a judicial or administrative decision\n* Adults who are subject to a legal protection measure\n* Children less than 6 years old (in Lyon)","ALL","18 Years",{"count":105,"type":106},3500,"ESTIMATED","OBSERVATIONAL","The \" CirB-RNA \" cohort aims to create a biological collection associated with clinical and biological data from patients with hepatitis B infection. This project is part of a much larger program that aims to characterize and quantify circulating viral RNAs as a possible new biomarker of hepatitis B functional cure.",[110],"Hepatitis B","2026-05-20",{"date":113,"type":114},"2026-05-22","ACTUAL",{"date":116,"type":114},"2019-02-25",{"date":118,"type":106},"2029-06-25",{"name":5,"class":6},6]